Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2'-(2,3-bis(methoxycarbonyl)guanidino)-5'-phenylthio-2-methoxyacetanilide
2. Armadose
3. Bay Vh 5757
4. Dimethyl 2-(methoxyacetyl)amino-4-(phenylthio)phenyl(carbonimidoyl)bis(carbamate)
5. Rintal
1. 58306-30-2
2. Rintal
3. Combotel
4. Oratel
5. Bay Vh 5757
6. Negabot Plus Paste
7. Bay-vh-5757
8. Bay H 5757
9. Bay-h-5757
10. Febantel For Veterinary Use
11. Bayvh-5757
12. Bayh-5757
13. S75c401os1
14. Dimethyl ((2-(2-methoxyacetamido)-4-(phenylthio)phenyl)imidocarbonyl)dicarbamate
15. Cid 5361251
16. Ncgc00181307-01
17. Carbamic Acid, ((2-((methoxyacetyl)amino)-4-(phenylthio)phenyl)carbonimidoyl)bis-, Dimethyl Ester
18. Methyl N-[[2-[(2-methoxyacetyl)amino]-4-phenylsulfanylanilino]-(methoxycarbonylamino)methylidene]carbamate
19. Methyl N-[n'-[2-[(2-methoxyacetyl)amino]-4-phenylsulfanylphenyl]-n-methoxycarbonylcarbamimidoyl]carbamate
20. Febantelum
21. Febantelum [inn-latin]
22. Febantel [usan:inn:ban]
23. Bay Vh5757
24. Einecs 261-205-0
25. Brn 2195764
26. Unii-s75c401os1
27. Febantel;
28. Febantel-d6
29. Rintal (tn)
30. Febantel [usan]
31. Febantel (usan/inn)
32. Febantel [inn]
33. Febantel [mi]
34. Febantel [mart.]
35. Febantel [usp-rs]
36. 2'-(2,3-bis(methoxycarbonyl)guanidino)-5'-phenylthio-2-methoxyacetanilide
37. ((2-((methoxyacetyl)amino)-4-(phenylthio)phenyl)carbonimidoyl)bis(carbamic Acid), Dimethyl Ester
38. Dsstox_cid_26898
39. Dsstox_rid_81999
40. N-(2-(2,3-bis-(methoxycarbonyl)-guanidino)-5-(phenylthio)-phenyl)-2-methoxyacetamide
41. Dsstox_gsid_46898
42. Febantel [green Book]
43. Schembl164634
44. Bay Vh-5757
45. Febantel For System Suitability
46. Chembl1080983
47. Dtxsid6046898
48. Chebi:189104
49. Amy22172
50. Bcp12934
51. Zinc4215999
52. Tox21_112782
53. Ac-424
54. Bdbm50103610
55. Mfcd01738527
56. S5092
57. Akos015905606
58. Akos015994747
59. Akos030242485
60. Ccg-269196
61. Cs-3978
62. Db11409
63. Ks-5048
64. N-{2-[2,3-bis-(methoxycarbonyl)-guanido]-5-(phenylthio)-phenyl}-2-methoxyacetamide
65. Carbamic Acid,[[2-[(methoxyacetyl)amino]-4-(phenylthio)phenyl]carbonimidoyl]bis-,dimethyl Ester
66. Hy-17597
67. Cas-58306-30-2
68. F0922
69. Ft-0655929
70. Febantel, Vetranal(tm), Analytical Standard
71. C75732
72. D04135
73. 306f302
74. A831825
75. Febantel For Veterinary Use [ep Monograph]
76. Sr-01000944939
77. Q1399337
78. Sr-01000944939-1
79. W-105401
80. Febantel, European Pharmacopoeia (ep) Reference Standard
81. Febantel, United States Pharmacopeia (usp) Reference Standard
82. Febantel For System Suitability, European Pharmacopoeia (ep) Reference Standard
83. (e)-methyl (2-(2-methoxyacetamido)-4-(phenylthio)phenylamino)(methoxycarbonylamino)methylenecarbamate
84. Carbamic Acid, N,n'-[[2-[(2-methoxyacetyl)amino]-4-(phenylthio)phenyl]carbonimidoyl]bis-, Dimethyl Ester
85. Dimethyl [(z)-((2-[(methoxyacetyl)amino]-4-(phenylsulfanyl)phenyl)amino)methylylidene]biscarbamate
86. Methyl (2-(2-methoxyacetamido)-4-(phenylthio)phenylamino)(methoxycarbonylamino)methylenecarbamate
87. Methyl (ne)-n-[[2-[(2-methoxyacetyl)amino]-4-phenylsulfanylanilino]-(methoxycarbonylamino)methylidene]carbamate
88. Methyl N-[n'-[2-[(2-methoxyacetyl)amino]-4-phenylsulanylphenyl]-n-methoxycarbonylcarbamimidoyl]carbamate
89. N-(((2-(2-methoxyacetamido)-4-(phenylsulfanyl)phenyl)amino)((methoxycarbonyl)imino)methyl)carbamate
| Molecular Weight | 446.5 g/mol |
|---|---|
| Molecular Formula | C20H22N4O6S |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 10 |
| Exact Mass | 446.12600561 g/mol |
| Monoisotopic Mass | 446.12600561 g/mol |
| Topological Polar Surface Area | 153 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 621 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anthelmintics
Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)
Antiprotozoal Agents
Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)
API SUPPLIERS
Emay Pharmaceuticals is a GMP-certified API manufacturing company.
Jai Radhe Sales is your partner for all your sourcing needs.
NDC Package Code : 86055-0018
Start Marketing Date : 2019-11-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 6168
Submission : 2016-10-05
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : DRONTAL PLUS
Dosage Form : TABLET
Dosage Strength : 113.4MG
Packaging :
Approval Date :
Application Number : 2169517
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : DRONTAL PLUS
Dosage Form : TABLET
Dosage Strength : 340.2MG
Packaging :
Approval Date :
Application Number : 2169525
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : India
Brand Name : VERMITOSS
Dosage Form : Oral Suspension
Dosage Strength : 14.4MG; 15.0MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
36
PharmaCompass offers a list of Febantel API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Febantel manufacturer or Febantel supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Febantel manufacturer or Febantel supplier.
PharmaCompass also assists you with knowing the Febantel API Price utilized in the formulation of products. Febantel API Price is not always fixed or binding as the Febantel Price is obtained through a variety of data sources. The Febantel Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Febantel manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Febantel, including repackagers and relabelers. The FDA regulates Febantel manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Febantel API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Febantel manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Febantel supplier is an individual or a company that provides Febantel active pharmaceutical ingredient (API) or Febantel finished formulations upon request. The Febantel suppliers may include Febantel API manufacturers, exporters, distributors and traders.
click here to find a list of Febantel suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Febantel as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Febantel API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Febantel as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Febantel and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Febantel NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Febantel suppliers with NDC on PharmaCompass.
Febantel Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Febantel GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Febantel GMP manufacturer or Febantel GMP API supplier for your needs.
A Febantel CoA (Certificate of Analysis) is a formal document that attests to Febantel's compliance with Febantel specifications and serves as a tool for batch-level quality control.
Febantel CoA mostly includes findings from lab analyses of a specific batch. For each Febantel CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Febantel may be tested according to a variety of international standards, such as European Pharmacopoeia (Febantel EP), Febantel JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Febantel USP).
